Walleye Trading
AKRO

Walleye Trading’s Akero Therapeutics AKRO Stock Holding History

Walleye Trading’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-116,054
Closed -$2.79M – 4688
2023
Q4 		$2.71M Buy
116,054
+491
+0.4% +$9.68K 0.01% 1695
2023
Q3 		$5.85M Buy
115,563
+68,112
+144% +$3.17M 0.02% 1009
2023
Q2 		$2.22M Buy
47,451
+38,186
+412% +$1.75M 0.01% 1579
2023
Q1 		$354K Sell
9,265
-25,023
-73% -$1.12M ﹤0.01% 3092
2022
Q4 		$1.88M Buy
34,288
+21,455
+167% +$919K 0.01% 1733
2022
Q3 		$437K Buy
+12,833
New +$196K ﹤0.01% 3025

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Walleye Trading's AKRO Position: Q1 2024 in Review

Walleye Trading sold out of Akero Therapeutics (AKRO) in Q1 2024, closing a stake of 116,054 shares — an estimated $2.79M sold.

Walleye Trading first reported a position in AKRO in Q3 2022 and held it in 6 quarters. The position peaked at $5.85M in Q3 2023. 173 funds tracked by Wall St. Rank hold AKRO as of Q1 2024.

  • Walleye Trading reported no remaining Akero Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Walleye Trading sold 116,054 Akero Therapeutics shares in Q1 2024, an estimated $2.79M.
  • Walleye Trading first reported a position in Akero Therapeutics in Q3 2022 and held it in 6 quarters.
  • Walleye Trading's Akero Therapeutics position peaked at $5.85M in Q3 2023.
  • 173 funds tracked by Wall St. Rank held Akero Therapeutics as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.